Air Lease Names Grant Newman as Treasurer
LOS ANGELES, March 17, 2025--(BUSINESS WIRE)--Air Lease (NYSE: AL) announced today the appointment of Grant Newman as Senior Vice President and Treasurer, effective March 17.
Grant Newman is an experienced finance, strategy and aviation executive, with over 20 years in finance, more than 15 of which have been in aviation and aerospace. He most recently served as the CFO of Elroy Air, an aerospace start-up, from 2021-2025, where he led the finance, supply chain, government affairs and legal departments. Prior to that Grant was SVP, Strategy & Corporate Development at Era Helicopters where he led the company's M&A, capital markets and strategic initiatives including the divestiture of DART Aerospace and Era's $1.5 billion merger with Bristow Helicopters. He subsequently served as the combined company's Treasurer & Head of Investor Relations. Grant began his professional career in 2001 at General Electric (GE), where he graduated from GE's Financial Management Program and was certified as a Lean Six Sigma Black Belt. He also spent a decade as an investment banker at Deutsche Bank covering transportation, aviation, and commercial aerospace. Grant has an MBA from Duke University and received an MS in Finance as well as a BS with a double major in Economics and Government & Politics from the University of Maryland, College Park.
"We are pleased to have Grant join the Air Lease team," said Gregory B. Willis, Executive Vice President and Chief Financial Officer of Air Lease. "Grant's strong background in corporate finance and aviation brings years of experience to the Treasurer role."
About Air Lease (NYSE: AL)
Air Lease is a leading global aircraft leasing company based in Los Angeles, California. Air Lease and its team of dedicated and experienced professionals are principally engaged in purchasing new commercial aircraft and leasing them to its airline customers worldwide through customized aircraft leasing and financing solutions. The company routinely posts information that may be important to investors in the "Investors" section of its website at www.airleasecorp.com. Investors and potential investors are encouraged to consult Air Lease's website regularly for important information. The information contained on, or that may be accessed through, Air Lease's website is not incorporated by reference into, and is not a part of, this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250317426353/en/
Contacts
Investors:Jason ArnoldVice President, Investor RelationsEmail: investors@airleasecorp.com Media:Ashley ArnoldSenior Manager, Media and Investor RelationsEmail: press@airleasecorp.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
If You Invested $10K In Weyerhaeuser Stock 10 Years Ago, How Much Would You Have Now?
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Weyerhaeuser Co. (NYSE:WY) is a real estate investment trust, which owns or controls approximately 11 million acres of timberlands in the U.S. and manages additional timberlands under long-term licenses in Canada. The company's stock traded at approximately $31.85 per share 10 years ago. If you had invested $10,000, you could have bought roughly 314 shares. Currently, shares trade at $25.67, meaning your investment's value could have declined to $8,060 from stock price depreciation. However, Weyerhaeuser also paid dividends during these 10 years. Don't Miss: Invest Where It Hurts — And Help Millions Heal: If there was a new fund backed by Jeff Bezos offering a ? Weyerhaeuser's dividend yield is currently 3.27%. Over the last 10 years, it has paid about $13.15 in dividends per share, which means you could have made $4,128 from dividends alone. Summing up $8,060 and $4,128, we end up with the final value of your investment, which is $12,188. This is how much you could have made if you had invested $10,000 in Weyerhaeuser stock 10 years ago. This means a total return of 21.88%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 237.37%. Weyerhaeuser has a consensus rating of "Buy" and a price target of $35.17 based on the ratings of 13 analysts. The price target implies around 37% potential upside from the current stock price. Trending: With Point, you can On April 24, the company announced its Q1 2025 earnings, posting adjusted EPS of $0.11, beating the consensus estimate of $0.10, and revenues of $1.76 billion, in line with expectations, as reported by Benzinga. "We delivered solid results across each of our businesses in the first quarter," said CEO Devin W. Stockfish. "In addition, we increased our quarterly base dividend for the fourth consecutive year. I'm pleased with the organization's performance, particularly in light of the uncertain macroeconomic backdrop. Turning to our outlook, we are well positioned to navigate a range of market conditions in the near term, and we remain confident about the longer-term demand fundamentals that support our businesses." Given the expected upside potential, growth-focused investors may find Weyerhaeuser stock attractive. Furthermore, they can benefit from the company's solid dividend yield of 3.27%. Check out this article by Benzinga for three more stocks offering high dividend yields. Read Next: Maximize saving for your retirement and cut down on taxes: . , which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum. Image: Shutterstock This article If You Invested $10K In Weyerhaeuser Stock 10 Years Ago, How Much Would You Have Now? originally appeared on Sign in to access your portfolio
Yahoo
6 hours ago
- Yahoo
HSBC Upgrades Dr. Reddy's Laboratories Limited (RDY) to Buy from Hold
On June 5, HSBC upgraded Dr. Reddy's Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of earnings potential and solid market standing. A worker at a biopharmaceutical facility packaging an active pharmaceutical ingredient. HSBC's updated estimates for FY2026 to FY2028 take into account the shifting market tide for semaglutide and gRevlimid. The analysts are waiting for semaglutide to be introduced in Canada, Brazil, and India at the beginning of FY2027, which is a greater leap from their prior hypothesis of a launch only in Canada by Q4 of FY2026. The analysts revised their FY2026 sales figures for Dr. Reddy's Laboratories Limited (NYSE:RDY)'s gRevlimid, noting the growing competition. The adjustment includes a 5.1% decrease in the EPS estimate for FY2026, while the EPS forecast for FY2027 and FY2028 grew by 12% to 13%. According to HSBC analysts, the expected surge in semaglutide sales will strengthen Dr. Reddy's earnings. HSBC assigned a new price target for RDY's American Depositary Receipts (ADR) as well, raising it from $14.44 to $16.90. Dr. Reddy's Laboratories Limited (NYSE:RDY) is a global pharma company based in Hyderabad, India, that makes both branded and generic medicines for a wide range of health conditions. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. While we acknowledge the potential of RDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
UBS Upholds Buy Recommendation on Deckers Outdoor (DECK)
On June 5, UBS analysts maintained a Buy rating on Deckers Outdoor Corporation (NYSE:DECK) with a price target of $169. The analysts expect Decker's EPS to top market estimates over the coming year as sales projections increase for its Hoka brand. They also anticipate UGG to keep up its record as a major global casual footwear brand. A customer browsing a retail store, finding the perfect footwear for their casual outfits. The analysts were confident that Deckers Outdoor Corporation (NYSE:DECK) could deliver a low double-digit compound annual sales growth. They forecast that this growth could drive Deckers' forward PE ratio over 20x, compared to the present 16.7x. The $169 price target by UBS reflects a 60% upside for DECK. The stock has plummeted nearly 47% over the last six months, which signals a buying opportunity. After discussions with company management on June 4, the analysts were optimistic about Deckers Outdoor Corporation (NYSE:DECK)'s potential for growth. Despite the market showing caution with reference to the Hoka brand's capacity to sustain robust growth, UBS believes that DECK is perfectly tackling concerns about industry competition, evolving fashion trends, and dependence on Clifton and Bondi franchises. The analysts see double-digit revenue growth for Hoka in the next few years. Deckers Outdoor Corporation (NYSE:DECK) designs and markets premium footwear and apparel worldwide with brands like UGG and HOKA. The company was established in 1973 and is headquartered in Goleta, California. While we acknowledge the potential of DECK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Sign in to access your portfolio
